Conagen develops debondable adhesive for textiles and soft materials from natural bioingredients

Sustainable hot melt adhesives pave the way for textile reworking and recycling.

Bedford, Mass., July 11, 2023 (GLOBE NEWSWIRE) — When more than 92 million tons of textile waste are landfilled annually, new solutions are needed to enable fabric reworking in manufacturing and recycling on a mass scale. Conagen, the biotechnology innovator, announced the development of a groundbreaking debondable textile adhesive made from high-performance materials sourced from sustainable and natural biomolecules.

Conagen’s debondable adhesive offers a major application in the realm of reworkability during clothing production. Traditionally, when mistakes occur during manufacturing, it can lead to material wastage and additional production costs.

The reworkability aspect of Conagen’s adhesive presents a game-changing solution for the clothing industry. It allows for quick and efficient correction of errors without the need to discard and waste valuable materials. Adjustments can be made by simply debonding the adhesive and the fabric components can be seamlessly reworked, resulting in improved production efficiency, reduced material waste, and significant cost savings for manufacturers.

Moreover, debonding textile fabric plays a vital role in textile recycling by enabling efficient material separation, preserving material quality, expanding recycling opportunities, and advancing the goals of a circular economy.

Traditional adhesives used in garment manufacturing often create a permanent bond, making it challenging to separate fabric components during recycling. Conagen’s debondable adhesive not only drives sustainability through fabric recycling but also offers a practical and economical solution for optimizing production processes in the clothing industry. The ability to debond and rework materials bring newfound flexibility and efficiency, benefiting manufacturers and the environment.
Top of Form
Bottom of Form

“Conagen’s pioneering adhesive has unlocked new possibilities and opportunities. This groundbreaking development enables efficient material separation during reworking and recycling processes and preserves the integrity of textile fibers, ensuring their quality for future utilization,” stated Sara Johnson, senior materials scientist. “With the introduction of Conagen’s adhesive, we are taking a significant stride towards achieving a more sustainable and environmentally responsible textile industry.”

Having previously created debondable adhesives for other sectors, such as appliances, smartphones, cars, and more, Conagen identified the significant benefits such an adhesive could bring to the textile and clothing industry and tailored a new product specifically to its needs.

Adhesives and tapes are commonly used today in garment manufacturing, either alone or in combination with stitching. This is particularly evident in the manufacturing of women’s underwear, where up to six layers of material are often glued together to achieve the desired fit and comfort. It is essential to bring attention to these modern manufacturing methods as they reflect the evolution of textile production.

Conagen’s new adhesive offering provides strength comparable to existing fabric adhesives but with the added feature of controlled debondability at end-of-life. Inspired by self-healing materials, Conagen utilizes sustainable and natural ingredients to create high-strength debondable hot melt adhesives. Unlike traditional offerings, this new adhesive is designed with reversibility, exhibiting the strength of conventionally cured adhesives, with the added benefit of transitioning to a flowable material after heating.

Conagen’s high-strength debondable textile adhesive can be used for garments, but also extends to accessories and other soft goods applications. Furthermore, the technology is compatible with both natural and synthetic fibers and materials.

To develop sustainable debondable textile adhesives, Conagen leverages its precision fermentation technology, independent of plant source materials, to create more efficient and sustainable bio-based ingredients compared to chemically-synthesized versions.

Conagen’s fermentation technology is forging a path towards a more sustainable future, where the utilization of sustainable biocompounds and biomaterials takes center stage in propelling high-performance solutions that prioritize environmental consciousness,” said J. McNamara, vice president of chemical applications.

The seam tapes market stood at $128 million in 2020. It was projected to exhibit a CAGR of 6.9% between 2020 and 2025, making Conagen’s adhesive formulation lucrative for a supplier to distribute to clothing manufacturers.

Debondable adhesives have the potential to significantly impact the market by offering a more sustainable and efficient solution for fabric bonding. The ability to easily debond materials could lead to increased adoption of adhesive-based manufacturing techniques and open up new opportunities for textile reworking and recycling, thereby potentially expanding the market for debondable adhesive products.

Conagen’s hallmark in biotech specialty and industrial space lies in discovering applications from the platform of natural biocompounds and biomaterials, ushering in a new era of high-performing and sustainable materials.

“By harnessing the power of fermentation, Conagen is leading the charge in promoting greener alternatives and revolutionizing industries with its commitment to sustainability and innovation,” said McNamara.

Conagen’s commitment to green chemicals and sustainability has been greatly reinforced by its strategic partnership with Sumitomo Chemical. The collaboration represents a major step forward in their shared vision of developing biosolutions for a more sustainable future.

About Conagen

Conagen is a product-focused, synthetic biology R&D company with large-scale manufacturing capabilities. Our scientists and engineers use the latest synthetic biology tools to develop high-quality, sustainable, nature-based products by precision fermentation and enzymatic bioconversion. We focus on the bioproduction of high-value ingredients for food, nutrition, flavors and fragrances, pharmaceutical, and renewable materials industries. www.conagen.com

Attachments

Ana Capretz, Head of Public Relations and Communications
Conagen
+1-781-271-1588
ana.capretz@conagen.com

GlobeNewswire Distribution ID 8872187

Bridge International Academies highlights the importance of educating girls this World Population Day

Bridge Nigeria pupil in class

_SAM8621 (2)

Bridge Nigeria pupil in class

NAIROBI, Kenya, July 11, 2023 (GLOBE NEWSWIRE) — Bridge International Academies is drawing attention to the urgency of educating African girls this World Population Day (11th July) – the first time Sub-Saharan Africa will have the largest population of children on the planet.

The schools network, which includes Bridge Kenya, Bridge Nigeria and Bridge Uganda, supports children and parents in underserved communities by providing an excellent education.

This World Population Day focuses on the theme of ‘gender equality and women’s empowerment as a key factor in reducing poverty.’

Reuben Wambugu, Bridge Group Managing Director, said, “By 2050 Africa and Asia will be home to 85% of the world’s young people, with the larger proportion in Africa. Currently, only 10% of children in sub-Saharan Africa are able to read a simple sentence by the age of 10. If these young people aren’t provided with an adequate education, there will be a global shortage of scientists, doctors and engineers. This could lead to a range of possible global catastrophes. Educating women and girls has proved particularly effective in reducing poverty on a local level in the short term. And with the children of educated women shown to be healthier and better educated, this leads to faster and sustained poverty reduction through generations.

He continued, “While Bridge has seen fantastic improvements in learning outcomes for all those attending our schools, it is particularly heartening that Bridge’s methodology has succeeded in achieving gender parity in the classroom. A new study by Nobel Prize winning economist Professor Michael Kremer in our Bridge Kenya schools confirms this, finding girls make the same leaps in learning as boys.”

Speaking on the success of Bridge’s methods, Bridge Nigeria Managing Director Foyinsola Akinjayeju said, “Bridge’s model focuses on arming teachers with scientifically proven techniques to elevate the learning of girls. Through approaches, such as gender sensitive instruction in lesson and textbook materials, expecting equal participation through ‘cold calling’ of boys and girls in the classroom and the use of female school leaders as role models, girls are empowered to succeed. By pushing this approach and the importance of women’s empowerment, Bridge Nigeria alone has provided a life-changing education to tens of thousands of girls in underserved communities, helping them complete primary school, do well in secondary school and open up opportunities offering prosperity and success.”

To learn more about the Bridge methodology – visit their website here.

You can reach out to Bridge International Academies at info@bridgeinternationalacademies.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/db9775c7-c35b-483b-b919-d894909f989d

GlobeNewswire Distribution ID 1000829295

Ambiq Propels Remote Healthcare Monitoring Sector Growth with New Ultra-Low Power Processors

The Apollo4 Lite and Apollo4 Blue Lite System-on-Chips (SoCs) Help Enhance Devices’ Functionalities and Battery Life to Accelerate the Adoption of Remote Monitoring

Apollo4 Lite and Apollo4 Blue Lite: Anyone, Anytime, Anywhere

Ambiq introduces Apollo4 Lite and Apollo4 Blue Lite

News Highlights:

  • The new Apollo4 Lite and Blue Lite SoCs offer feature-rich capability, optimized memory, powerful graphics performance, and secureSPOT® for robust security in a lightweight solution
  • Ideal for digital health applications, such as digital stethoscopes, patient monitoring, and continuous glucose and blood pressure monitoring
  • The Apollo4 Blue Lite offers secure Bluetooth® Low Energy connectivity for communication to handheld devices, host equipment, and the Cloud

AUSTIN, Texas, July 10, 2023 (GLOBE NEWSWIRE) — Ambiq®, a technology leader in ultra-low power semiconductor products and solutions, introduces the Apollo4 Lite and Apollo4 Blue Lite SoC to its expanding portfolio of SoCs for IoT endpoint devices, especially the remote monitoring products of the healthcare sector. This announcement follows Ambiq’s release of its Heart Kit™, an optimized open-source AI model utilizing multi-head neural networks (MH-NNs) to enable a variety of real-time heart-monitoring applications.

The Apollo4 Lite and Blue Lite product line is the latest generation system processor solutions built upon Ambiq’s proprietary Subthreshold Power-Optimized Technology (SPOT®) platform, enabling new features while reducing devices’ overall system power consumption to extend their battery life. Both SoCs are embedded with an ultra-low power Cortex-M4 core that can operate at up to 192 MHz with turboSPOT, an audio subsystem, GPU, and ample MRAM and SRAM. They are also conveniently pin-compatible with Ambiq’s Apollo4 Plus and Blue Plus¹, providing developers with optimum flexibility for innovation.

“Today’s patients are more empowered to monitor and advocate for their own health, and healthcare providers require more data analytics to prescribe holistic treatment,” said David Priscak, VP of Technical Solutions at Ambiq. “With bold graphics and long battery life, state-of-the-art health tracking is now more affordable and accessible thanks to these new additions to our Apollo4 SoC family.”

Apollo4 Lite / Blue Lite Chart

Apollo4 Lite / Blue Lite Chart

“The global remote patient market in terms of revenue was estimated to be worth $53.6 billion in 2022 and is poised to reach $175.2 billion by 2027, growing at a CAGR of 26.7% from 2022 to 2027,” said Ms. Anu Dhiman – Lead Healthcare Analyst – MarketsandMarkets Research Pvt. Ltd. “The predominant factors influencing the growth of the market include the benefits of remote patient monitoring to reduce the burden on medical resources, the monitoring benefits of telehealth and remote patient monitoring services, advancements in telecommunications, as increasing geriatric population, and the growing need to expand healthcare access.”

The Apollo4 Lite and the Apollo4 Blue Lite are designed for extended battery life, advanced security, and powerful graphics in small form factors, which are critical for the continued adoption of these devices. Both are now in mass production, targeting digital health products, smartwatches, fitness bands, animal trackers, voice-activated remotes, industrial maintenance, and smart home IoT devices. For more product information, visit www.ambiq.com/apollo4-lite and www.ambiq.com/apollo4-blue-lite.

¹ – Apollo4 Lite is pin-compatible with Apollo4 Plus (AMAP42KP-KBR); Apollo4 Blue Lite is pin-compatible with Apollo4 Blue Plus (AMA4B2KP-KXR.)

About Ambiq

Ambiq’s mission is to develop the lowest-power semiconductor solutions to enable intelligent devices everywhere by developing the lowest-power semiconductor solutions to drive a more energy-efficient, sustainable, and data-driven world. Ambiq has helped leading manufacturers worldwide develop products that last weeks on a single charge (rather than days) while delivering a maximum feature set in compact industrial designs. Ambiq’s goal is to take Artificial Intelligence (AI) where it has never gone before in mobile and portable devices, using Ambiq’s advanced ultra-low power system on chip (SoC) solutions. Ambiq has shipped more than 200 million units as of March 2023. For more information, visit www.ambiq.com.

Contact

Charlene Wan
VP of Branding, Marketing, and Investor Relations
cwan@ambiq.com
+1.512.879.2850

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/620a2f10-acfe-4d54-b9c3-0983c58c06f6

https://www.globenewswire.com/NewsRoom/AttachmentNg/fd179ebf-2f60-4195-8fca-b88c7b7a852c

GlobeNewswire Distribution ID 8870834

Ambiq Impulsiona Crescimento do Setor de Monitoramento Remoto de Saúde com Novos Processadores de Energia Ultrabaixa

Apollo4 Lite e Apollo4 Blue Lite System-on-Chips (SoCs) Ajudam a Melhorar as Funcionalidades e a Vida Útil da Bateria dos Dispositivos para Acelerar a Adoção do Monitoramento Remoto

Apollo4 Lite e Apollo4 Blue Lite: Qualquer Pessoa, Qualquer Hora, Qualquer Lugar

Ambiq introduz Apollo4 Lite e Apollo4 Blue Lite

Novos Destaques:

  • Os novos SoCs Apollo4 Lite e Blue Lite oferecem recursos ricos em funcionalidades, memória otimizada, desempenho gráfico potente e secureSPOT® para segurança robusta em uma solução leve
  • Ideal para aplicações de saúde digital, como estetoscópios digitais, monitoramento de pacientes, e monitoramento contínuo de glicose e pressão arterial
  • O Apollo4 Blue Lite oferece conectividade segura Bluetooth® de baixa energia para comunicação com dispositivos portáteis, equipamentos host e a nuvem

AUSTIN, Texas, July 10, 2023 (GLOBE NEWSWIRE) — A Ambiq®, líder em tecnologia de produtos e soluções de semicondutores de potência ultrabaixa, incluiu o SoC Apollo4 Lite e Apollo4 Blue Lite no seu portfólio de SoCs em expansão para dispositivos de endpoint IoT, especialmente produtos de monitoramento remoto do setor de saúde. Este anúncio dá seguimento ao lançamento da Ambiq do seu Heart Kit™, um modelo otimizado de IA de código aberto que utiliza redes neurais de múltiplas cabeças (MH-NNs) para viabilizar uma variedade de aplicativos de monitoramento cardíaco em tempo real.

A linha de produtos Apollo4 Lite e Blue Lite é uma solução de processador de sistema de última geração criada com base na plataforma proprietária Subthreshold Power-Optimized Technology (SPOT®) da Ambiq, que viabiliza novos recursos e reduz o consumo geral de energia do sistema dos dispositivos para prolongar a vida útil da bateria. Ambos os SoCs são incorporados com um núcleo Cortex-M4 de potência ultrabaixa que pode operar a até 192 MHz com turboSPOT, um subsistema de áudio, GPU e ampla MRAM e SRAM. Eles também são convenientemente compatíveis com o Apollo4 Plus e Blue Plus¹ da Ambiq, proporcionando aos desenvolvedores a flexibilidade ideal para a inovação.

“Os pacientes de hoje estão mais capacitados para monitorar e defender sua própria saúde, e os profissionais de saúde exigem mais análise de dados para prescrever tratamento holístico”, disse David Priscak, VP de Soluções Técnicas da Ambiq. “Com gráficos ousados e longa duração da bateria, o rastreamento de saúde de última geração agora é mais em conta e acessível graças a essas novas adições à nossa família Apollo4 SoC.”

Gráfico Apollo4 Lite/Blue Lite

Gráfico Apollo4 Lite/Blue Lite

“O mercado global de pacientes remotos em termos de receita foi estimado em US$53,6 bilhões em 2022 e deve chegar a US$175,2 bilhões até 2027, crescendo a um CAGR de 26,7% de 2022 a 2027”, disse a Sra. Anu Dhiman – Analista Líder de Saúde – MarketsandMarkets da Research Pvt. Ltd. “Os fatores predominantes que influenciam o crescimento do mercado incluem os benefícios do monitoramento remoto de pacientes para reduzir a carga sobre os recursos médicos, os benefícios de monitoramento de serviços de telessaúde e monitoramento remoto de pacientes, avanços em telecomunicações, como o aumento da população geriátrica e a crescente necessidade de expandir o acesso à saúde.”

A Apollo4 Lite e a Apollo4 Blue Lite são projetadas para uma vida útil prolongada da bateria, segurança avançada e gráficos potentes em pequenos formatos que são essenciais para a adoção contínua desses dispositivos. Ambos estão agora em produção em massa e voltados para os produtos de saúde digital, smartwatches, pulseiras de fitness, rastreadores de animais, controles remotos ativados por voz, manutenção industrial e dispositivos IoT domésticos inteligentes. Para mais informação sobre o produto, visite www.ambiq.com/apollo4-lite e www.ambiq.com/apollo4-blue-lite.

¹ – Apollo4 Lite é compatível com pinos com Apollo4 Plus (AMAP42KP-KBR); Apollo4 Blue Lite é compatível com pinos com Apollo4 Blue Plus (AMA4B2KP-KXR.)

Sobre a Ambiq

A Ambiq tem por missão desenvolver soluções de semicondutores de nível mais baixo de energia para habilitar dispositivos inteligentes em todos os lugares, desenvolvendo soluções de semicondutores de nível mais baixo de energia para impulsionar um mundo mais eficiente em termos de energia, sustentável e orientado por dados. A Ambiq ajudou os principais fabricantes em todo o mundo a desenvolver produtos que duram semanas com uma única carga (em vez de dias), ao mesmo tempo em que oferecem um conjunto máximo de recursos em designs industriais compactos. O objetivo da Ambiq é levar a Inteligência Artificial (IA) a áreas nunca alcançadas em dispositivos móveis e portáteis, com o uso de soluções avançadas de sistema em chip (SoC) de energia ultrabaixa da Ambiq. A Ambiq entregou mais de 200 milhões de unidades até março de 2023. Para mais informação, visite www.ambiq.com.

Contato

Charlene Wan
VP de Marca, Marketing e Relações com Investidores
cwan@ambiq.com
+1.512.879.2850

Fotos deste comunicado podem ser encontradas em

https://www.globenewswire.com/NewsRoom/AttachmentNg/620a2f10-acfe-4d54-b9c3-0983c58c06f6/pt

https://www.globenewswire.com/NewsRoom/AttachmentNg/fd179ebf-2f60-4195-8fca-b88c7b7a852c/pt

GlobeNewswire Distribution ID 8871063

Ambiq propulse la croissance du secteur de la surveillance des soins de santé à distance avec de nouveaux processeurs à ultra-basse consommation

Les systèmes sur puces (SoC) Apollo4 Lite et Apollo4 Blue Lite contribuent à améliorer les fonctionnalités et l’autonomie des appareils afin d’accélérer l’adoption de la surveillance à distance

Apollo4 Lite et Apollo4 Blue Lite : n’importe qui, n’importe quand, n’importe où

Ambiq lance l’Apollo4 Lite et l’Apollo4 Blue Lite

Faits saillants de cette actualité :

  • Les nouveaux SoC Apollo4 Lite et Blue Lite offrent de nombreuses fonctionnalités, une mémoire optimisée, des performances graphiques puissantes et secureSPOT® pour une sécurité renforcée dans une solution légère
  • Il s’agit de produits idéaux pour les applications de santé numérique, comme les stéthoscopes numériques ainsi que les appareils de surveillance des patients et de contrôle de la pression artérielle et de la glycémie en continu
  • L’Apollo4 Blue Lite offre une connectivité Bluetooth® à basse consommation sécurisée pour la communication avec les appareils portatifs, les périphériques hôtes et le Cloud

AUSTIN, Texas, 10 juill. 2023 (GLOBE NEWSWIRE) — Ambiq®, un leader technologique des solutions et produits à semi-conducteurs et ultra-basse consommation, ajoute les SoC Apollo4 Lite et Apollo4 Blue Lite à son portefeuille en expansion de SoC pour les périphériques de point de terminaison de l’IdO, en particulier les produits de surveillance à distance du secteur de la santé. Cette annonce fait suite an lancement par Ambiq de son Heart Kit™, un modèle à IA open-source optimisé utilisant des réseaux neuraux à têtes multiples (multi-head neural networks, MH-NN) afin de permettre une variété d’applications de surveillance cardiaque en temps réel.

La gamme de produits Apollo4 Lite et Blue Lite se compose des solutions de processeurs système de la toute dernière génération s’appuyant sur la plateforme exclusive Subthreshold Power-Optimized Technology (SPOT®) d’Ambiq, permettant d’accéder à de nouvelles fonctions tout en réduisant la consommation énergétique globale des appareils afin de prolonger leur autonomie. Les deux SoC intègrent un cœur Cortex-M4 à ultra-basse consommation pouvant fonctionner à une fréquence qui peut atteindre 192 MHz avec turboSPOT, un sous-système audio, un processeur graphique ainsi qu’une MRAM et une SRAM importantes. Très pratiques, ils sont aussi compatibles avec les broches des Apollo4 Plus et Blue Plus¹ d’Ambiq, offrant aux développeurs une flexibilité optimale pour innover.

« Les patients d’aujourd’hui sont davantage habilités à surveiller et à protéger leur propre santé, et les prestataires de soins de santé requièrent davantage d’analyses des données pour prescrire un traitement holistique », a déclaré David Priscak, VP des solutions techniques chez Ambiq. « Avec des graphismes audacieux et une longue autonomie, il est désormais plus facile que jamais d’accéder à un suivi abordable de la santé à la pointe de la technologie grâce à ces nouveaux ajouts à notre gamme de SoC Apollo4. »

Tableau sur l’Apollo4 Lite / Blue Lite

Tableau sur l’Apollo4 Lite / Blue Lite

« Le chiffre d’affaires du marché mondial de la surveillance des patients à distance a été estimé à 53,6 milliards USD en 2022 et devrait atteindre 175,2 milliards USD d’ici 2027, en se développant selon un TCAC de 26,7 % entre 2022 et 2027 », a commenté  Mme Anu Dhiman, analyste de santé en chef chez MarketsandMarkets Research Pvt. Ltd. « Les facteurs prédominants qui influencent la croissance du marché comprennent les avantages de la surveillance des patients à distance afin de réduire la fardeau pesant sur les ressources médicales, les avantages en termes de contrôle de la télésanté et des services de surveillance des patients à distance, les avancées des télécommunications, l’accroissement de la population gériatrique et le besoin grandissant d’étendre l’accès aux soins de santé. »

L’Apollo4 Lite et l’Apollo4 Blue Lite sont conçus pour une autonomie accrue, une sécurité avancée et de puissants graphismes au sein de petits facteurs de forme, qui sont des aspects cruciaux pour l’adoption continue de ces appareils. Les deux solutions sont maintenant produites en masse, ciblant les produits de santé numérique, les montres connectées, les bandes d’exercice, les localisateurs d’animaux, les télécommandes à activation vocale, la maintenance industrielle et les appareils employant l’IdO pour l’habitation intelligente. Pour plus d’informations sur les produits, veuillez consulter les pages www.ambiq.com/apollo4-lite et www.ambiq.com/apollo4-blue-lite.

¹ – L’Apollo4 Lite est compatible avec les broches de l’Apollo4 Plus (AMAP42KP-KBR) ; l’Apollo4 Blue Lite est compatible avec les broches de l’Apollo4 Blue Plus (AMA4B2KP-KXR).

À propos d’Ambiq

Ambiq a pour mission de développer les solutions à semi-conducteurs les moins gourmandes en énergie pour permettre l’utilisation d’appareils intelligents sur toute la planète en vue de favoriser un monde plus éco-énergétique, durable et piloté par les données. Ambiq aide des fabricants de premier plan du monde entier à développer des produits ayant une autonomie de plusieurs semaines (au lieu de quelques jours) tout en offrant un ensemble de fonctions maximal dans des conceptions industrielles compactes. L’objectif d’Ambiq est d’amener l’intelligence artificielle (IA) là où elle n’a jamais été auparavant au sein de dispositifs portables et mobiles en utilisant ses solutions avancées à système sur puce (SoC) et ultra-basse consommation. En mars 2023, Ambiq avait déjà expédié plus de 200 millions d’unités. Pour tout complément d’information, veuillez consulter le site www.ambiq.com.

Contact

Charlene Wan
VP du branding, du marketing et des relations avec les investisseurs
cwan@ambiq.com
+1.512.879.2850

Les photographies accompagnant ce communiqué de presse sont disponibles aux adresses :

https://www.globenewswire.com/NewsRoom/AttachmentNg/620a2f10-acfe-4d54-b9c3-0983c58c06f6/fr

https://www.globenewswire.com/NewsRoom/AttachmentNg/fd179ebf-2f60-4195-8fca-b88c7b7a852c/fr

GlobeNewswire Distribution ID 8871063